Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Cao, Yang  [Clear All Filters]
2013
Liu J, Ruan B, You N, Huang Q, Liu W, Dang Z, Xu W, Zhou T, Ji R, Cao Y, et al. Downregulation of miR-200a Induces EMT Phenotypes and CSC-like Signatures through Targeting the β-catenin Pathway in Hepatic Oval Cells. PLoS One. 2013;8(11):e79409.
2014
Wei J, Xu J, Cao Y, Zhou J, Zhang Y. Allogeneic Stem-Cell Transplantation for Peripheral T-Cell Lymphoma: A Systemic Review and Meta-Analysis. Acta Haematol. 2014;133(2):136-144.
Han Z, Wang X, Ma L, Chen L, Xiao M, Huang L, Cao Y, Bai J, Ma D, Zhou J, et al. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer. Oncotarget. 2014.
2016
Ding Z-C, Liu C, Cao Y, Habtetsion T, Kuczma M, Pi W, Kong H, Cacan E, Greer SF, Cui Y, et al. IL-7 signaling imparts polyfunctionality and stemness potential to CD4(+) T cells. Oncoimmunology. 2016;5(6):e1171445.
2018
Ge L, Wang Y, Cao Y, Li G, Sun R, Teng P, Wang Y, Bi Y, Guo Z, Yuan Y, et al. MiR-429 improved the hypoxia tolerance of human amniotic cells by targeting HIF-1α. Biotechnol Lett. 2018.
Wang S, Deng S, Cao Y, Zhang R, Wang Z, Jiang X, Wang J, Zhang X, Zhang J, Liu G, et al. Overexpression of Toll-Like Receptor 4 Contributes to Phagocytosis of Salmonella Enterica Serovar Typhimurium via Phosphoinositide 3-Kinase Signaling in Sheep. Cell Physiol Biochem. 2018;49(2):662-677.
2020
Han Z, Xu Z, Chen L, Ye D, Yu Y, Zhang Y, Cao Y, Djibril B, Guo X, Gao X, et al. Iron overload inhibits self-renewal of human pluripotent stem cells via DNA damage and generation of reactive oxygen species. FEBS Open Bio. 2020.
2021
Cao Y, Yi X, Wang N, Wang GX, Huang L, Hong Z, Meng L, Zhou X, Wang J, Hao X, et al. CD19/CD22 CAR T cell Cocktail Therapy Following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas: Combined CAR T Cell Therapy and Transplantation. Transplant Cell Ther. 2021.
He L, Zhang J, Guo D, Tian H, Cao Y, Ji X, Zhan Y. Establishment of the technology of cambial meristematic cells (CMCs) culture from shoots and high expression of FmPHV (PHAVOLUTA) functions in identification and differentiation of CMCs and promoting the shoot regeneration by hypocotyl in Fraxinus mandshu. Plant Physiol Biochem. 2021;160:352-364.
2022
Liu W, Ji J, Zou D, Cao Y, Xu Y, Zhou J, Gao S, Wang F, Chen W, Du J, et al. Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone Marrow Transplant. 2022.
Shi L, Zheng Y, Cheng Z, Ji N, Niu C, Wang Y, Huang T, Li R, Huang M, Chen X, et al. One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment. Stem Cell Res Ther. 2022;13(1):321.
2023
Cao Y, Zhang C, Zhao X, Huang J, Zhang Z, Jiang C, Mo X, Hu X. Allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia patients with nucleoporin 98 (NUP98) gene rearrangements: a real-world study in China. Bone Marrow Transplant. 2023.
Cheng P, Wang Q-X, Wang L-L, Guan J, Zhou Y, Zhang T, Su F, Chen L-Q, Cao Y, Cheng H, et al. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023;31(3):896-901.
Wu Z, Wang X, Shi J, Gupta A, Zhang Y, Zhang B, Cao Y, Wang L. Identification of Functional Modules and Key Pathways Associated with Innervation in Graft Bone-CGRP Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via p38 MAPK and Wnt6/-Catenin. Stem Cells Int. 2023;2023:1154808.
Niu Q, Chen H, Ou Q, Yang S, Peng Y, Xie Y, Yu L, Cheng Z, Cao Y, Wang Y. Klotho enhances bone regenerative function of hPDLSCs via modulating immunoregulatory function and cell autophagy. J Orthop Surg Res. 2023;18(1):400.
Chen Z, Gan L, Chen X, Zheng J, Shi S, Wu L, Cao Y. LncRNA HOTAIRM1 promotes dental follicle stem cell-mediated bone regeneration by regulating HIF-1α/KDM6/EZH2/H3K27me3 axis. J Cell Physiol. 2023.
Lv Q, Cao Y, Wang J, Meng L, Wang GX. Metagenomic Next-generation Sequencing May be a Tool for Timely Diagnosis of Seronegative and Primary Toxoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review. Pediatr Infect Dis J. 2023.
Cao Y, Marcucci EC, Budde LE. Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting. J Hematol Oncol. 2023;16(1):69.
Li Y, Wang N, Zhang X, Cao Y, Zhang L, Liu A, Zhang Y. Post-transplantation cyclophosphamide as GVHD prophylaxis in allogenic hematopoietic stem cell transplantation: Recent advances and modification. Blood Rev. 2023:101078.
Lin Y, Gu Q, Lu S, Pan Z, Yang Z, Li Y, Yang S, Lv Y, Zheng Z, Sun G, et al. Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease. J Clin Invest. 2023.
Zhou J, Wang Z, Wang H, Cao Y, Wang GX. Sustained efficacy of chimeric antigen receptor T-cell therapy in central nervous system lymphoma: a systematic review and meta-analysis of individual data. Front Pharmacol. 2023;14:1331844.
2024
Li N, Zhang R, Wang J, Zhu X, Meng F, Cao Y, Wang GX, Yang Y. Case report: Acute HHV6B encephalitis/myelitis post CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell lymphoma. Front Neurol. 2024;15:1334000.
Zhang S, Zhou X, Zhang S, Wang N, Zhang T, Zhang D, Ao Q, Cao Y, Huang L. EBV-associated lymphoproliferative disease post-CAR-T cell therapy. Front Med. 2024.
Xin X, Zhu X, Yang Y, Wang N, Wang J, Xu J, Wei J, Huang L, Zheng M, Xiao Y, et al. Efficacy of programmed cell death 1 inhibitor maintenance after chimeric antigen receptor T cells in patients with relapsed/refractory B-cell non-Hodgkin-lymphoma. Cell Oncol (Dordr). 2024.
Lando D, Ma X, Cao Y, Jartseva A, Stevens TJ, Boucher W, Reynolds N, Montibus B, Hall D, Lackner A, et al. Enhancer-promoter interactions are reconfigured through the formation of long-range multiway hubs as mouse ES cells exit pluripotency. Mol Cell. 2024.

Pages